NASDAQ:APTO
$0.760
(
7.07%
)
Friday, 27th Jan 2023
Aptose Biosciences Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $0.437 | $0.760 | Friday, 27th Jan 2023 APTO stock ended at $0.760. This is 7.07% more than the trading day before Thursday, 26th Jan 2023. During the day the stock fluctuated 8.57% from a day low at $0.700 to a day high of $0.760. |
| 90 days | $0.426 | $0.790 | |
| 52 weeks | $0.426 | $1.55 |
Historical Aptose Biosciences prices
| Date | Open | High | Low | Close | Volume |
| 2023-01-27 | $0.710 | $0.760 | $0.700 | $0.760 | 367 445 |
| 2023-01-26 | $0.700 | $0.720 | $0.700 | $0.710 | 150 644 |
| 2023-01-25 | $0.700 | $0.720 | $0.690 | $0.705 | 247 984 |
| 2023-01-24 | $0.700 | $0.710 | $0.680 | $0.700 | 326 207 |
| 2023-01-23 | $0.700 | $0.700 | $0.671 | $0.690 | 165 470 |
| 2023-01-20 | $0.663 | $0.680 | $0.650 | $0.680 | 86 323 |
| 2023-01-19 | $0.674 | $0.674 | $0.631 | $0.651 | 197 047 |
| 2023-01-18 | $0.680 | $0.700 | $0.630 | $0.660 | 238 100 |
| 2023-01-17 | $0.720 | $0.720 | $0.680 | $0.680 | 313 000 |
| 2023-01-13 | $0.670 | $0.710 | $0.660 | $0.700 | 505 079 |
| 2023-01-12 | $0.670 | $0.760 | $0.640 | $0.680 | 772 518 |
| 2023-01-11 | $0.630 | $0.650 | $0.630 | $0.646 | 105 242 |
| 2023-01-10 | $0.620 | $0.660 | $0.620 | $0.640 | 238 600 |
| 2023-01-09 | $0.620 | $0.659 | $0.620 | $0.643 | 106 253 |
| 2023-01-06 | $0.650 | $0.650 | $0.620 | $0.630 | 237 400 |
| 2023-01-05 | $0.610 | $0.670 | $0.600 | $0.650 | 176 413 |
| 2023-01-04 | $0.598 | $0.617 | $0.580 | $0.610 | 81 706 |
| 2023-01-03 | $0.594 | $0.610 | $0.580 | $0.600 | 122 860 |
| 2022-12-30 | $0.500 | $0.580 | $0.500 | $0.580 | 383 825 |
| 2022-12-29 | $0.490 | $0.584 | $0.460 | $0.539 | 913 647 |
| 2022-12-28 | $0.440 | $0.470 | $0.437 | $0.470 | 233 159 |
| 2022-12-27 | $0.456 | $0.470 | $0.426 | $0.436 | 345 047 |
| 2022-12-23 | $0.460 | $0.480 | $0.456 | $0.456 | 223 678 |
| 2022-12-22 | $0.480 | $0.490 | $0.456 | $0.458 | 240 684 |
| 2022-12-21 | $0.510 | $0.520 | $0.460 | $0.460 | 360 031 |
| 2022-12-20 | $0.510 | $0.520 | $0.460 | $0.474 | 552 809 |
| 2022-12-19 | $0.540 | $0.557 | $0.500 | $0.503 | 319 561 |
| 2022-12-16 | $0.600 | $0.610 | $0.510 | $0.525 | 452 050 |
| 2022-12-15 | $0.620 | $0.655 | $0.585 | $0.585 | 454 008 |
| 2022-12-14 | $0.650 | $0.655 | $0.636 | $0.647 | 469 428 |
| 2022-12-13 | $0.668 | $0.710 | $0.645 | $0.650 | 675 486 |
| 2022-12-12 | $0.730 | $0.737 | $0.621 | $0.710 | 2 317 263 |
| 2022-12-09 | $0.705 | $0.720 | $0.680 | $0.700 | 351 219 |
| 2022-12-08 | $0.710 | $0.730 | $0.690 | $0.710 | 166 749 |
| 2022-12-07 | $0.720 | $0.720 | $0.695 | $0.720 | 93 475 |
| 2022-12-06 | $0.690 | $0.730 | $0.688 | $0.720 | 83 450 |
| 2022-12-05 | $0.708 | $0.720 | $0.690 | $0.698 | 131 954 |
| 2022-12-02 | $0.652 | $0.730 | $0.652 | $0.730 | 254 242 |
| 2022-12-01 | $0.666 | $0.688 | $0.660 | $0.667 | 68 808 |
| 2022-11-30 | $0.687 | $0.687 | $0.650 | $0.665 | 92 775 |
| 2022-11-29 | $0.679 | $0.690 | $0.645 | $0.678 | 100 930 |
| 2022-11-28 | $0.700 | $0.710 | $0.673 | $0.680 | 163 082 |
| 2022-11-25 | $0.680 | $0.705 | $0.680 | $0.702 | 82 378 |
| 2022-11-23 | $0.653 | $0.675 | $0.640 | $0.670 | 188 038 |
| 2022-11-22 | $0.639 | $0.670 | $0.635 | $0.653 | 97 414 |
| 2022-11-21 | $0.700 | $0.700 | $0.630 | $0.650 | 154 988 |
| 2022-11-18 | $0.673 | $0.673 | $0.637 | $0.655 | 54 979 |
| 2022-11-17 | $0.650 | $0.667 | $0.640 | $0.650 | 329 689 |
| 2022-11-16 | $0.699 | $0.699 | $0.670 | $0.672 | 111 808 |
| 2022-11-15 | $0.710 | $0.720 | $0.661 | $0.680 | 168 281 |
About Aptose Biosciences
Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology primarily in the United States. Its clinical programs include APTO-253, which is in Phase 1a/b clinical trial for the treatment of patients with relapsed or refractory blood cancers, including acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (HR MDS); and HM43239 that is in Ph... APTO Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
